tradingkey.logo

Autonomix Medical Inc

AMIX
0.909USD
-0.101-10.03%
Fechamento 11/04, 16:00ETCotações atrasadas em 15 min
3.66MValor de mercado
PerdaP/L TTM

Autonomix Medical Inc

0.909
-0.101-10.03%

Mais detalhes de Autonomix Medical Inc Empresa

Autonomix Medical, Inc. is a medical device company, which is focused on advancing technologies to treat diseases involving the peripheral nervous system. Its technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate peripheral neural signals with up to 1,000 times sensitivity. It is developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation, and chronic pain management across a disease spectrum. Its Autonomix catheter is equipped with a microchip that converts analog signals from the body to a digital signal that can be sent directly to a computer screen.

Informações de Autonomix Medical Inc

Código da empresaAMIX
Nome da EmpresaAutonomix Medical Inc
Data de listagemJan 29, 2024
CEOMr. Bradley (Brad) Hauser
Número de funcionários8
Tipo de títulosOrdinary Share
Fim do ano fiscalJan 29
Endereço21 Waterway Ave, Suite 300
CidadeTHE WOODLANDS
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal77380
Telefone18322777816
Sitehttps://autonomix.com/
Código da empresaAMIX
Data de listagemJan 29, 2024
CEOMr. Bradley (Brad) Hauser

Executivos da empresa Autonomix Medical Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
101.31K
--
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
35.77K
--
Mr. Bradley (Brad) Hauser
Mr. Bradley (Brad) Hauser
President, Chief Executive Officer
President, Chief Executive Officer
11.25K
--
Mr. David Andrew Robins
Mr. David Andrew Robins
Independent Director
Independent Director
10.98K
--
Mr. Trent N. Smith
Mr. Trent N. Smith
Chief Financial Officer
Chief Financial Officer
3.75K
--
Dr. Christopher Capelli, M.D.
Dr. Christopher Capelli, M.D.
Independent Director
Independent Director
3.75K
--
Mr. Walter V. Klemp
Mr. Walter V. Klemp
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Ms. Lori H. Bisson
Ms. Lori H. Bisson
Executive Vice Chairman of the Board
Executive Vice Chairman of the Board
--
--
Mr. Jonathan P. Foster
Mr. Jonathan P. Foster
Independent Director
Independent Director
--
--
Ms. Jenene Thomas
Ms. Jenene Thomas
Investor Relations
Investor Relations
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
101.31K
--
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
35.77K
--
Mr. Bradley (Brad) Hauser
Mr. Bradley (Brad) Hauser
President, Chief Executive Officer
President, Chief Executive Officer
11.25K
--
Mr. David Andrew Robins
Mr. David Andrew Robins
Independent Director
Independent Director
10.98K
--
Mr. Trent N. Smith
Mr. Trent N. Smith
Chief Financial Officer
Chief Financial Officer
3.75K
--
Dr. Christopher Capelli, M.D.
Dr. Christopher Capelli, M.D.
Independent Director
Independent Director
3.75K
--

Detalhamento da receita

Sem dados
Sem dados
Por Empresa
Por Região
Sem dados

Distribuição de ações

Atualizado em: qui, 25 de set
Atualizado em: qui, 25 de set
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Klemp (Walter V.)
2.43%
BioStar Ventures III, L.P.
1.95%
Heights Capital Management, Inc.
1.87%
Toth (Landy)
1.64%
Mariner Wealth Advisors
1.62%
Outro
90.48%
Investidores
Investidores
Proporção
Klemp (Walter V.)
2.43%
BioStar Ventures III, L.P.
1.95%
Heights Capital Management, Inc.
1.87%
Toth (Landy)
1.64%
Mariner Wealth Advisors
1.62%
Outro
90.48%
Tipos de investidores
Investidores
Proporção
Individual Investor
5.78%
Investment Advisor
3.96%
Corporation
1.95%
Hedge Fund
0.37%
Research Firm
0.27%
Investment Advisor/Hedge Fund
0.16%
Outro
87.51%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
35
294.89K
4.76%
-159.85K
2025Q2
39
859.06K
17.01%
+144.42K
2025Q1
38
911.14K
32.77%
+69.62K
2024Q4
37
970.61K
39.41%
+334.04K
2024Q3
33
498.18K
43.25%
+16.51K
2024Q2
26
438.67K
42.98%
+436.93K
2024Q1
16
314.97K
29.85%
+314.97K

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Klemp (Walter V.)
150.75K
2.43%
--
--
Sep 19, 2025
BioStar Ventures III, L.P.
120.82K
1.95%
--
--
Jun 30, 2025
Heights Capital Management, Inc.
116.09K
1.87%
-18.91K
-14.01%
Dec 31, 2024
Toth (Landy)
101.31K
1.64%
--
--
Sep 19, 2025
Mariner Wealth Advisors
100.64K
1.62%
--
--
Jun 30, 2025
Foster (Jonathan P.)
36.56K
0.59%
--
--
Sep 19, 2025
Schwartz (Robert)
35.77K
0.58%
--
--
Sep 19, 2025
Susquehanna International Group, LLP
20.47K
0.33%
+20.47K
--
Jun 30, 2025
Ikarian Capital LLC
20.00K
0.32%
--
--
Jun 30, 2025
Virtu Americas LLC
15.68K
0.25%
+15.68K
--
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: dom, 2 de nov
Atualizado em: dom, 2 de nov
Nome
Proporção
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proporção0%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Data
Tipo
Proporção
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
KeyAI